? Proposed Changes to Singapore’s Patents Act 2008 & Its Impact on Drug Regulation
This article was first published in the newsletter Pulse IP & Technology in February 2008. We would like to acknowledge and thank Alban Tay Mahtani & de Silva LLP for allowing us to reproduce and include the article in our eBulletin.
In this article, Patent Attorney, Mr. Edmund Kok, reports about the proposed changes to Singapore Patents Act and how it would impact the pharmaceutical industry, particularly in situations such as national emergencies or other circumstances of extreme urgency. The full article is found below.
**********
